Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Azfar Zaman.

Newcastle AuthorsTitleYearFull text
Professor Azfar Zaman
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI2022
Professor Azfar Zaman
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study2022
Professor Azfar Zaman
Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study2022
Dr Mohaned Egred
Dr Mohammad Alkhalil
Professor Azfar Zaman
Coronary revascularization in patients with left ventricle systolic dysfunction, current challenges and clinical outcomes2022
Stephen Hoole
Professor Azfar Zaman
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study2022
Dr Mohaned Egred
Professor Azfar Zaman
Dr Mohammad Alkhalil
Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock2022
Dr Rajiv Das
Dr Richard Edwards
Professor Azfar Zaman
Dr Mohammad Alkhalil
Prognostic Role of Sex-Specific Flow Threshold in Patients UndergoingTranscatheter Aortic Valve Replacement2022
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction2022
Professor Azfar Zaman
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial2021
Dr Jake McClements
Dr Katarina Novakovic
Professor Azfar Zaman
Professor Ioakim Spyridopoulos
Dr Marloes Peeters
et al.
Immobilization of Molecularly Imprinted Polymer Nanoparticles onto Surfaces using Different Strategies: Evaluating the Influence of the Functionalised Interface on the Performance of a Thermal Assay for the Detection of Cardiac Biomarker Troponin I2021
Professor Azfar Zaman
Dr Qaiser Aleem
Pharmacology before, during and after percutaneous coronary intervention2021
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr David Austin
Professor Azfar Zaman
et al.
Prevalence, Predictors and Outcomes of Thyroid Dysfunction in patients with Acute Myocardial Infarction: the ThyrAMI-1 Study2021
Dr Ben Beska
Dr Ashfaq Mohammed
Dr Rajiv Das
Dr Richard Edwards
Professor Azfar Zaman
et al.
Role of coronary angiogram before transcatheter aortic valve implantation2021
Professor Azfar Zaman
Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study2021
Dr Mark De Belder
Professor Azfar Zaman
Survival relative to pacemaker status after transcatheter aortic valve implantation2021
Dr Simon Findlay
Professor Azfar Zaman
A comparison of cardiovascular risk scores in native and migrant South Asian populations2020
Dr Avais Jabbar
Lorna Ingoe
Dr Shahid Junejo
Dr Peter Carey
Dr Honey Thomas
et al.
Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial2020
Dr Mohaned Egred
Dr Alan Bagnall
Professor Ioakim Spyridopoulos
Dr Rajiv Das
Professor Azfar Zaman
et al.
Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study2020
Professor Azfar Zaman
One-Month dual antiplatelet therapy following percutaneous coronary intervention with zotarolimus-eluting stents in high-bleeding-risk patients2020
Dr Subhi Akleh
Professor Azfar Zaman
Dr Rajiv Das
Dr Richard Edwards
Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices2020
Dr Bilal Bawamia
Dr Mohaned Egred
Dr Matthew Jackson
Dr David Austin
Professor Azfar Zaman
et al.
Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality2020
Dr Salman Razvi
Dr Avais Jabbar
Dr Arjola Bano
Lorna Ingoe
Dr Peter Carey
et al.
Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study2020
Professor Azfar Zaman
Dr Mohaned Egred
Dr Alan Bagnall
Dr Jannath Ahmed
Dr Richard Edwards
et al.
Smoking status and mortality outcomes following percutaneous coronary intervention2020
Professor Azfar Zaman
Dr Mark De Belder
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis2020
Professor Azfar Zaman
Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome2019
Professor Azfar Zaman
Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices2019
Professor Azfar Zaman
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy2019
Professor Azfar Zaman
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial2019
Professor Azfar Zaman
FDXR is a biomarker of radiation exposure in vivo2018
Professor Azfar Zaman
Dr Mohaned Egred
Professor Thomas Johnson
Dr Mark De Belder
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry2018
Professor Azfar Zaman
Orbita – Much ado about nothing?2018
Dr Sophie Gu
Professor Christopher Eggett
Dr Hani Ali
Professor Azfar Zaman
Dr Richard Edwards
et al.
Percutaneous Coronary Intervention for Left Ventricular Systolic Dysfunction2018
Professor Azfar Zaman
Dr Qaiser Aleem
Reducing cardiovascular risk in patients with type 2 diabetes mellitus2018
Dr Matthew Jackson
Dr David Austin
Muhammad Rashid
Dr Mark De Belder
Professor Azfar Zaman
et al.
The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society2018
Dr Salman Razvi
Dr Avais Jabbar
Professor Azfar Zaman
Thyroid Hormones and Cardiovascular Function and Diseases2018
Dr Mark De Belder
Professor Azfar Zaman
Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts2017
Dr Karthik Balasubramaniam
Dr Kelvin Lee
Muhammad Rashid
Professor Azfar Zaman
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus2017
Professor Azfar Zaman
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry2017
Dr Mark De Belder
Professor Azfar Zaman
The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry2017
Dr Avais Jabbar
Professor Simon Pearce
Professor Azfar Zaman
Dr Salman Razvi
Thyroid hormones and cardiovascular disease2017
Professor Azfar Zaman
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): The PLATINUM PLUS all-comers randomised trial2017
Dr Mohaned Egred
Dr Ayush Khurana
Dr Alan Bagnall
Professor Azfar Zaman
1-Year Follow-Up Optical Frequency Domain Imaging of Multiple Bioresorbable Vascular Scaffolds for the Treatment of Spontaneous Coronary Artery Dissection2016
Dr Mark De Belder
Professor Azfar Zaman
Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database2016
Professor Azfar Zaman
Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication2016
Professor Azfar Zaman
Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFRCT RIPCORD Study2016
Dr Avais Jabbar
Dr Ashfaq Mohammed
Dr Ayush Khurana
Dr Rajiv Das
Professor Azfar Zaman
et al.
Local versus general anaesthesia in transcatheter aortic valve replacement – a tertiary centre experience2016
Dr Avais Jabbar
Dr Ayush Khurana
Dr Ashfaq Mohammed
Dr Rajiv Das
Professor Azfar Zaman
et al.
Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement2016
Professor Azfar Zaman
Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention2016
Dr Mark De Belder
Professor Azfar Zaman
Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery2016
Professor Azfar Zaman
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries2016
Professor Azfar Zaman
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial2016
Professor Azfar Zaman
Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians2016
Dr Avais Jabbar
Dr Ayush Khurana
Dr Rajiv Das
Professor Azfar Zaman
Dr Richard Edwards
et al.
Transcatheter aortic valve replacement: a comparison of the direct flow medical and sapien 3 aortic valves2016
Professor Azfar Zaman
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries2016
Professor Azfar Zaman
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations.2015
Professor Vijay Kunadian
Professor Azfar Zaman
Dr Mark De Belder
Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS)2015
Professor Azfar Zaman
High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel2015
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society2015
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society2015
Professor Vijay Kunadian
Dr Murugu Veerasamy
Dr Hannah Sinclair
Dr Rajiv Das
Dr Richard Edwards
et al.
Major Adverse Cardiovascular Events at 30-days were not Significantly different between Frail and non-frail older ( ≥75 Years) Patients with non ST Elevation Acute Coronary Syndrome Managed by Invasive Strategy: An Analysis from the ICON1 Study2015
Professor Ioakim Spyridopoulos
Dr Javed Ahmed
Dr Rajiv Das
Dr Richard Edwards
Dr Alan Bagnall
et al.
Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention2015
Professor Azfar Zaman
Professor Bernard Keavney
Dr Mark De Belder
Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-122015
Dr Stephen Boag
Dr Rajiv Das
Dr Evgeniya Shmeleva
Dr Alan Bagnall
Dr Mohaned Egred
et al.
T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients2015
Dr Avais Jabbar
Professor Simon Pearce
Professor Azfar Zaman
Dr Salman Razvi
Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial2015
Dr Karthik Balasubramaniam
Professor Azfar Zaman
Antiplatelet Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Retrospective Observational Study of Prasugrel and Clopidogrel2014
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Professor Azfar Zaman
Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study2014
Dr Girish Viswanathan
Dr Karthik Balasubramaniam
Emerita Professor Sally Marshall
Professor Azfar Zaman
Dr Salman Razvi
et al.
Blood Thrombogenicity is Independently Associated with Serum TSH Levels in Post-Non-ST Elevation Acute Coronary Syndrome2014
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Dr Karthik Balasubramaniam
Professor Azfar Zaman
Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.2014
Professor Azfar Zaman
Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? The RIPCORD Study2014
Dr Stephen Boag
Dr Rajiv Das
Dr Mohaned Egred
Professor Azfar Zaman
Dr Alan Bagnall
et al.
Dynamic Changes in T-Lymphocyte Counts Following Primary Percutaneous Coronary Intervention Predict Infarct Size and Microvascular Obstruction2014
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society2014
Dr Murugu Veerasamy
Dr Alan Bagnall
Professor Azfar Zaman
Multi-vessel coronary artery disease is associated with early, but not late, mortality following primary percutaneous coronary intervention2014
Professor Vijay Kunadian
Dr Bilal Bawamia
Professor Azfar Zaman
Outcomes Following Primary Percutaneous Coronary Intervention in the Setting of Cardiac Arrest: A Registry Database Study2014
Professor Azfar Zaman
Switching from transfemoral to transradial access for PCI: A single-center learning curve over 5 years2014
Dr Girish Viswanathan
Dr Karthik Balasubramaniam
Professor Azfar Zaman
Emerita Professor Sally Marshall
Thrombogenicity in obese patients with Type 2 diabetes following non ST-elevation acute coronary syndrome: is inflammation the missing link?2014
Dr Karthik Balasubramaniam
Dr Rajiv Das
Professor Vijay Kunadian
Professor Azfar Zaman
Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction2013
Dr Karthik Balasubramaniam
Dr Rajiv Das
Professor Vijay Kunadian
Professor Azfar Zaman
Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: An Observational Study2013
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Andini Natasari
Jessica Tarn
Dr Dennis Lendrem
et al.
Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome2013
Dr Girish Viswanathan
Dr Kathryn White
Professor Azfar Zaman
Emerita Professor Sally Marshall
Clopidogrel alters thrombus quantity and quality in Type 2 diabetes2013
Professor Vijay Kunadian
Dr Bilal Bawamia
Professor Azfar Zaman
Drug eluting stents versus bare metal stents in primary PCI2013
Professor Vijay Kunadian
Dr Bilal Bawamia
Dr Murugu Veerasamy
Sheila Jamieson
Professor Azfar Zaman
et al.
Gender Comparisons in Cardiogenic Shock During ST Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention2013
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Dr Salman Razvi
Professor Azfar Zaman
et al.
Higher Thrombus Burden in Patients with Subclinical Hypothyroidism after Non ST Elevation Acute Coronary Syndrome2013
Professor Azfar Zaman
Dr Javed Ahmed
Dr Mohaned Egred
Professor Ioakim Spyridopoulos
Professor Bernard Keavney
et al.
Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome2013
Professor Azfar Zaman
Dr Javed Ahmed
Dr Mohaned Egred
Dr Richard Edwards
Professor Ioakim Spyridopoulos
et al.
Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome2013
Dr Girish Viswanathan
Dr Karthik Balasubramaniam
Dr Bilal Bawamia
Emerita Professor Sally Marshall
Professor Azfar Zaman
et al.
Higher thrombus, altered clot kinetics and fibrin architecture in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome2012
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy2012
Professor Vijay Kunadian
Professor Azfar Zaman
Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study2012
Professor Vijay Kunadian
Professor Azfar Zaman
Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study2012
Professor Vijay Kunadian
Professor Azfar Zaman
Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study2012
Professor Vijay Kunadian
Professor Azfar Zaman
Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies2012
Professor Vijay Kunadian
Professor Azfar Zaman
Saphenous vein graft percutaneous coronary intervention via radial artery access: Safe and effective with reduced hospital length of stay2012
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Dr Karthik Balasubramaniam
Professor Azfar Zaman
Thrombus and antiplatelet therapy in type 2 diabetes mellitus: A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina2012
Dr Girish Viswanathan
Professor Azfar Zaman
Unfractionated Heparin during Elective PCI: Fixed Dose or Weight Adjusted?2012
Professor Azfar Zaman
Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras2011
Dr Bilal Bawamia
Sheila Jamieson
Professor Azfar Zaman
Evaluating a nurse led triage process in treating patients with left bundle branch block (LBBB) referred for primary percutaneous coronary intervention (pPCI)2011
Dr Bilal Bawamia
Sheila Jamieson
Professor Azfar Zaman
Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI)2011
Dr Bilal Bawamia
Sheila Jamieson
Professor Azfar Zaman
Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI)2011
Dr Girish Viswanathan
Anthony Hildreth
Professor Azfar Zaman
Health Related Quality of Life After Percutaneous Coronary Revascularisation in Patients with Previous Coronary Artery Bypass Grafts: A Two-Year Follow Up Study2011
Professor Vijay Kunadian
Professor Azfar Zaman
Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies2011
Professor Vijay Kunadian
Professor Azfar Zaman
Professor Ioakim Spyridopoulos
Sodium bicarbonate for the prevention of contrast induced nephropathy: A meta-analysis of published clinical trials2011
Dr Girish Viswanathan
Professor Azfar Zaman
Better clinical outcomes of participants in clinical research: Trial effect of an observational study in patients with non ST elevation acute coronary syndrome (NSTE-ACS)2010
Professor Azfar Zaman
Dr Asif Shah
Changing Characteristics and Outcomes of Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction: a Study Across Therapeutic Eras2010
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Evaluation of Thrombus in Patients with Type 2 Diabetes Mellitus After Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS): Increased Amount and Altered Strength2010
Dr Girish Viswanathan
Dr Arun Natarajan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Higher Thrombus Burden and Impaired Clot Kinetics in Patients with Type 2 Diabetes Mellitus following Non ST-Elevation Acute Coronary Syndrome2010
Dr Girish Viswanathan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Thrombus burden and response to clopidogrel in patients with type 2 diabets mellitus presenting with non ST elevation acute coronary syndrome2010
Professor Azfar Zaman
Emeritus Professor David Mendelow
Dr Daniel Birchall
Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics2009
Dr Sharad Agarwal
Professor Azfar Zaman
Assessment of functional status and quality of life after percutaneous coronary revascularisation in octogenarians2009
Dr Girish Viswanathan
Sajid Javed
Sheila Jamieson
Professor Azfar Zaman
Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact ?2009
Dr Honey Thomas
Dr Peter Avery
Dr Javed Ahmed
Dr Richard Edwards
Professor Azfar Zaman
et al.
Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis2009
Dr Arun Natarajan
Professor Azfar Zaman
Non-invasive assessment of saphenous vein graft patency in asymptomatic patients2009
Professor Azfar Zaman
Percutaneous coronary intervention in anticoagulated patients via radial artery access2009
Professor Azfar Zaman
Radial artery anomaly and its influence on transradial coronary procedural outcome2009
Professor Vijay Kunadian
Professor Azfar Zaman
Sodium Bicarbonate For The Prevention Of Contrast Induced Nephropathy: A Meta-Analysis2009
Professor Azfar Zaman
Transradial coronary angiography in children and adolescents2009
Professor Azfar Zaman
Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes2008
Professor Vijay Kunadian
Professor Azfar Zaman
Malignancy: An unrecognized risk factor for coronary stent thrombosis?2008
Dr Arun Natarajan
Professor Azfar Zaman
Emerita Professor Sally Marshall
Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents2008
Dr Arun Natarajan
Emerita Professor Sally Marshall
Professor Azfar Zaman
The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus2008
Dr Arun Natarajan
Professor Azfar Zaman
Antiplatelet therapy in acute coronary syndromes2007
Professor Azfar Zaman
Incidence of radial artery anatomic variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome.2007
Professor Azfar Zaman
Incidence of radial artery anatomical variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome2007
Professor Azfar Zaman
Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease2007
Dr Arun Natarajan
Professor Azfar Zaman
Thrombogenicity in type 2 diabetes and coronary artery disease2007
Dr Daniel Birchall
Professor Azfar Zaman
Emeritus Professor David Mendelow
Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics2006
Dr Arun Natarajan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Blood thrombogenicity is increased in patients with type 2 diabetes mellitus and stable coronary artery disease despite aspirin and statin therapy2006
Professor Azfar Zaman
Drug Insight: Antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation2006
Dr Arun Natarajan
Emerita Professor Sally Marshall
Professor Azfar Zaman
Patients with type 2 diabetes mellitus have higher thrombogenicity despite aspirin and statin therapy2005
Dr Arun Natarajan
Emerita Professor Sally Marshall
Dr John Hanley
Professor Azfar Zaman
Thrombogenicity of flowing blood is increased in patients with type 2 diabetes mellitus (T2DM) despite treatment with aspirin2005
Professor Azfar Zaman
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation2004
Dr Ewan Shepherd
Dr Chris Plummer
Professor Azfar Zaman
Dr Janet McComb
Mortality and symptom benefit with cardiac resynchronisation therapy (CRT) in severe heart failure2004
Professor Azfar Zaman
Predicting sudden death in patients with mild to moderate chronic heart failure2004
Anthony Hildreth
Dr Dominic Cox
Professor Azfar Zaman
Quality of life after percutaneous coronary intervention for patients with previous coronary artery bypass grafting2004
Professor Azfar Zaman
A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors2003
Professor Azfar Zaman
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction2003
Professor Azfar Zaman
Dr Asif Shah
Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation2002
Professor Azfar Zaman
Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure2002
Professor Azfar Zaman
Progression and Regression of Atherosclerotic Lesions Monitoring With Serial Noninvasive Magnetic Resonance Imaging2002
Professor Azfar Zaman
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control2001
Professor Azfar Zaman
Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study2001